Design and construction of protein chimeras to create a multi-component protein vaccine for the prevention of all forms of pneumococcal disease (#102)
8:30 PM
Exploiting bacterial lifestyles: a combined strategy for the treatment of Pseudomonas aeruginosa infections (#104)
8:30 PM
The Function of the cedA gene of Uropathogenic Escherichia coli and its importance in Urinary Tract Infections (#106)
8:30 PM
Small RNA-mediated regulation in Acinetobacter baumannii (#108)
8:30 PM
The role of Treponema denticola motility in polymicrobial biofilm formation (#110)
8:30 PM
Cell division as a target for the development of novel antimicrobial agents (#112)
8:30 PM
A subset of patients with urosepsis and Escherichia coli infection have specific antibodies that inhibit serum-mediated bactericidal killing. (#114)
8:30 PM
Global proteomic analysis of the early host response to Burkholderia pseudomallei infection (#116)
8:30 PM
Plasmid mobilisation in Staphylococcus aureus; is everybody doin’ it? (#118)
8:30 PM
PorV is an outer membrane surface shuttle protein for the Type IX Secretion System (#120)
8:30 PM
The role of the IS26 ends in conservative targeted cointegrate or transposon formation (#122)
8:30 PM
The use of φBT1 based integrative vectors in the genus nocardia (#124)
8:30 PM
Clostridium difficile toxins mediate thymic atrophy during infection (#126)
8:30 PM
Identification of mortise-tenon joints in outer membrane proteins and their influence on β-barrel stability (#128)
8:30 PM
Whole-genome Sequencing Reveals a New Cluster of Penicillin-resistant Serogroup W Neisseria meningitidis in Western Australia (#130)
8:30 PM
Characterization of Treponema denticola and Porphyromonas gingivalis cross-feeding (#132)
8:30 PM
Functional and structural analysis of the zinc efflux protein CzcD (#134)
8:30 PM
Emergence of pathogenic Klebsiella pneumoniae lineages through frequent acquisitions of iron-scavenging siderophores. (#136)
8:30 PM
The specificity of the wzx translocase in O antigen biosynthesis (#138)
8:30 PM
Developing a vaccine against Buruli ulcer using bioluminescent Mycobacterium ulcerans and a low-dose murine challenge model (#140)
8:30 PM
Development of high throughput assays to identify compounds that exploit cell wall deficient (CWD) Pseudomonas aeruginosa (#142)
8:30 PM
Identification of Pasteurella multocida small RNAs: unravelling the regulatory network (#144)
8:30 PM
Sugar transporter may dictate disease progression in Streptococcus pneumoniae serotype 14 (#146)
8:30 PM
Investigating glycan based interactions of Neisseria meningitidis (#148)
8:30 PM
The Sequence of the Mature Region of Secreted Proteins Impacts Signal Peptidase 1 Processing (#150)
8:30 PM
Zinc nutritional immunity and toxicity both play a role in control of Group A Streptococcus (#152)
8:30 PM
The role of Pht proteins in pneumococcal zinc acquisition (#154)
8:30 PM
TB under the sea: re-thinking the origins of Mycobacterium tuberculosis (#156)
8:30 PM
Investigation of the interaction between a Shigella adhesin and the host cell surface (#158)
8:30 PM
Origins of the 7th cholera pandemic strain – A phylogenetic tree that can be updated (#160)
8:30 PM
Coxiella burnetii metabolism and pathogenesis – how are they linked? (#162)
8:30 PM
Lectin activity is a common feature of the cholesterol-dependent cytolysins (CDCs) (#164)
8:30 PM
The role of polysaccharide capsule in Acinetobacter baumannii virulence (#166)
8:30 PM
Interaction of disease-causing Group A Streptococcus with innate immune pathways (#168)
8:30 PM
Elucidation of redox folding pathways in Salmonella and their contribution to copper resistance (#170)
8:30 PM
Molecular analysis of the transcriptional regulation of fedA and fedR operons by virulence regulatory protein FedR of the pig enterotoxigenic Escherichia coli (#172)
8:30 PM
Lost without translation: ribosome maturation by YbeY stabilises mRNAs encoding the type 3 secretion machine (#174)
8:30 PM
Unravelling the mystery of sticky velcro-like proteins from pathogenic Escherichia coli (#176)
8:30 PM
Targeting a major facilitator of bacterial virulence using a fragment-based drug discovery approach (#178)
8:30 PM
Genomic characterisation of Escherichia coli ST1193: an emerging fluoroquinolone-resistant variant of an O75-associated extra-intestinal pathogenic clonal group (#180)
8:30 PM
Contribution of the linker region in autotransporter assembly (#182)
8:30 PM